Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04162210
Brief Title: Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

First Submitted : November 11, 2019
First Submitted that Met QC Criteria : November 11, 2019
First Posted : November 14, 2019

Last Update Submitted that Met QC Criteria : February 26, 2021
Last Update Posted : March 1, 2021